Everyday Law · Court of Appeals for the D.C. Circuit
Aug 25, 2026
AI illustrationNorwich Pharmaceuticals wants final approval for a rifaximin generic. Did the deny it unfairly?
Your callDid the wrongly deny Norwich Pharmaceuticals final approval for its drug?
TL;DR
- 1Norwich Pharmaceuticals claims the wrongfully denied final approval for its rifaximin generic drug application.
- 2The argues that the first applicant's exclusivity still holds, blocking Norwich's approval for now.
- 3Norwich believes the first applicant should have lost its exclusivity by not marketing the drug timely. The disagrees.




